Clinical Trials in Miami

Showing 7021-7040 of 11,431 trials

Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)

NCT03028324

The purpose of this study is to assess the influence of transcranial magnetic stimulation (TMS) on speech performance in individuals with primary progressive apraxia of speech.

Apraxia Speech

University of Miami4 participantsStarted Aug 2017

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

NCT02637856

This study will evaluate the efficacy and safety of ocrelizumab in participants with RRMS who have had a suboptimal response to an adequate course of DMT. Participants will receive ocrelizumab as an initial dose of two 300-milligrams (mg) intravenous (IV) infusions (600 mg total) separated by 14 days followed by one 600-mg IV infusion for a maximum of 4 doses (up to 96 weeks). Anticipated time on study treatment is 96 weeks.

Multiple Sclerosis, Relapsing-Remitting

Genentech, Inc.608 participantsStarted Feb 2016

Cullman, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +79 more locations

Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

Find Trials by Condition in Miami

Non-invasive Buttock Lifting Induced by Magnetic Device - Multicentric Study

Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma

Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients

Eon™ FR Clinical Study Protocol 1064

Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)

A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Neurologic Complications in Spinal Deformity Surgery - Extension

Study Comparing OsseoSpeed™ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw